1-5 of 5
Theodore R Holman, PhD
Close
Sort by
Journal Articles

Novel 12-LOX Inhibitor ML355 Attenuates Platelet Reactivity and Impairs Thrombus Growth, Stability and Vessel Occlusion In Vivo

Reheman Adili, MD, Theodore R Holman, PhD, Michael Holinstat, PhD
Journal: Blood
Blood (2015) 126 (23): 3442.
https://doi.org/10.1182/blood.V126.23.3442.3442
Published: 2015
Journal Articles

12-HETrE, a Novel 12-LOX Oxylipin, Prevents Platelet Activation in a Gα s -like Manner

Jennifer Yeung, MS, Pilar Fernandez-Perez, BS, Joanne Vesci, MLT, Theodore R Holman, PhD, Jin Ren, PhD, Michael Holinstat, PhD
Journal: Blood
Blood (2014) 124 (21): 1436.
https://doi.org/10.1182/blood.V124.21.1436.1436
Published: 2014
Journal Articles

12-Lipoxygenase Regulates Platelet Reactivity and Thrombosis Through Formation Of Unique Oxylipins

Jennifer Yeung, MS, Pilar Fernandez-Perez, MS, Joanne Vesci, MLT, Theodore R Holman, PhD, Michael Holinstat, PhD
Journal: Blood
Blood (2013) 122 (21): 3515.
https://doi.org/10.1182/blood.V122.21.3515.3515
Published: 2013
Journal Articles

An ω-6 Fatty Acid, Dgla, Prevents Platelet Activation and Thrombosis in Vivo .

Jennifer Yeung, Kenneth Ikei, Joanne Vesci, MLT, Theodore R Holman, PhD, Michael Holinstat, PhD
Journal: Blood
Blood (2012) 120 (21): 2169.
https://doi.org/10.1182/blood.V120.21.2169.2169
Published: 2012
Journal Articles

12-HETrE, An Endogenous Inhibitor of Platelet Activation,

Jennifer Yeung, Kenneth Ikei, Joanne Vesci, MLT, Alex Arnouk, Theodore R Holman, PhD, Michael Holinstat, PhD
Journal: Blood
Blood (2011) 118 (21): 3254.
https://doi.org/10.1182/blood.V118.21.3254.3254
Published: 2011